))
Lower Blood Pressure Target Could Affect Millions
Archived series ("HTTP Redirect" status)
Replaced by: Science and Research Show
When?
This feed was archived on June 02, 2017 21:18 (
Why? HTTP Redirect status. The feed permanently redirected to another series.
What now? If you were subscribed to this series when it was replaced, you will now be subscribed to the replacement series. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 169808276 series 1032927
Content provided by The Scope Health Sciences Radio from the University of Utah. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Scope Health Sciences Radio from the University of Utah or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Results from the landmark Systolic Blood Pressure Intervention Trial (SPRINT) shows that a blood pressure target of 120 mmHg, lower than current guidelines, significantly reduces risk for heart failure, heart attacks and death. Implementing these findings into medical guidelines would be expected to affect at least 16.8 million Americans and could greatly reduce the incidence for heart disease in this country. Adam Bress, PharmD, assistant professor of pharmacotherapy at the University of Utah College of Pharmacy, explains who would most likely be affected by guideline changes, and the tough choices that physicians and patients could be faced with. His research was published in the Journal of the American College of Cardiology.
…
continue reading
128 episodes
Share
